Suppr超能文献

基于现有证据的 COVID-19 综合概述。

Comprehensive overview of COVID-19 based on current evidence.

机构信息

China Pharmaceutical University & Jiangsu Key Laboratory of Oncogenesis and Intervention, Nanjing, Jiangsu, China.

Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

出版信息

Dermatol Ther. 2020 Sep;33(5):e13525. doi: 10.1111/dth.13525. Epub 2020 May 22.

Abstract

In December 2019, twenty-seven pneumonia patients with unknown causes originated in South China seafood market in Wuhan. The virus infection spread rapidly and swept through China in less than a month. Subsequently, the virus was proven a novel coronavirus and named SARS-CoV-2. The outbreak of novel coronavirus has been determined as a Public Health Emergency of International Concern (PHEIC) by WHO on January 31, 2020. Similar to other coronaviruses like the Middle East Respiratory Syndrome (MERS) CoV and Severe Acute Respiratory Syndrome (SARS) CoV, the novel coronavirus was reported to spread via respiratory droplets and close contact from human to human, which means the virus is highly infectious and dangerous. Unfortunately, till now the virus has spread to over 200 countries/territories/areas around the world and the Coronavirus Disease 2019 (COVID-19) outbreak is continuing to grow. Currently, information sharing and transparency are essential for risk assessment and epidemic control in all endemic areas. In this article, we compared SARS-CoV-2 with SARS-CoV and influenza virus, discussed current researching progress of COVID-19, including clinical characteristics, pathological changes, treatment measures, and so on.

摘要

2019 年 12 月,27 例病因不明的肺炎患者起源于武汉华南海鲜市场。病毒感染迅速蔓延,不到一个月就席卷中国。随后,该病毒被证明是一种新型冠状病毒,并被世界卫生组织(WHO)命名为 SARS-CoV-2。2020 年 1 月 31 日,世界卫生组织将新型冠状病毒疫情确定为国际关注的突发公共卫生事件(PHEIC)。与其他冠状病毒(如中东呼吸综合征(MERS)CoV 和严重急性呼吸综合征(SARS)CoV)类似,新型冠状病毒据报道通过呼吸道飞沫和人与人之间的密切接触传播,这意味着该病毒具有高度传染性和危险性。不幸的是,截至目前,该病毒已传播到全球 200 多个国家/地区,2019 年冠状病毒病(COVID-19)疫情仍在持续蔓延。目前,信息共享和透明度对于所有流行地区的风险评估和疫情控制至关重要。在本文中,我们将 SARS-CoV-2 与 SARS-CoV 和流感病毒进行了比较,讨论了 COVID-19 的当前研究进展,包括临床特征、病理变化、治疗措施等。

相似文献

1
Comprehensive overview of COVID-19 based on current evidence.基于现有证据的 COVID-19 综合概述。
Dermatol Ther. 2020 Sep;33(5):e13525. doi: 10.1111/dth.13525. Epub 2020 May 22.
6
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
7
Coronavirus Disease 2019: Coronaviruses and Blood Safety.2019 年冠状病毒病:冠状病毒与血液安全。
Transfus Med Rev. 2020 Apr;34(2):75-80. doi: 10.1016/j.tmrv.2020.02.003. Epub 2020 Feb 21.

引用本文的文献

7
Hereditary Thrombophilia in the Era of COVID-19.新冠疫情时代的遗传性血栓形成倾向
Healthcare (Basel). 2022 May 27;10(6):993. doi: 10.3390/healthcare10060993.

本文引用的文献

3
Three Emerging Coronaviruses in Two Decades.二十年间出现的三种新型冠状病毒。
Am J Clin Pathol. 2020 Mar 9;153(4):420-421. doi: 10.1093/ajcp/aqaa029.
8
The progress of 2019 novel coronavirus event in China.2019新型冠状病毒事件在中国的进展。
J Med Virol. 2020 May;92(5):468-472. doi: 10.1002/jmv.25705. Epub 2020 Feb 26.
9
The global spread of 2019-nCoV: a molecular evolutionary analysis.2019-nCoV 在全球的传播:分子进化分析。
Pathog Glob Health. 2020 Mar;114(2):64-67. doi: 10.1080/20477724.2020.1725339. Epub 2020 Feb 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验